News and Events
Home >> Partnership >>News and Events
News and Events

Reported some success cases in treating Covid-19 patients with hydroxychloroquine sulfate
02 Apr 2020
Hydroxychloroquine is an appealing prospect because it’s already been tested in humans and is available in a low-cost generic form. Doctors in several countries, including the United States, France, China, and South Korea, have reported success in treating Covid-19 patients with hydroxychloroquine, sometimes paired with the antibiotic azithromycin. 
But these are anecdotes that don’t offer much insight into how effective the drug could be in a wider population.
DrSachaStelzer-Braid, a senior scientist in the virology research lab at the University of New South Wales and the Prince of Wales hospital, said while laboratory studies using hydroxychloroquineto inactivate the virus look promising, we still needed to be cautious about the possible use of the drug to shorten the duration of infection or even possibly prevent infection, if used prophylactically in healthcare workers.
Since March 2020, a novel coronavirus (COVID-19) has emerged in the world and spread rapidly to all corners of the world. But there is no specific drug at present. Hydroxychloroquine sulfate (chloroquine for short) has a wide range of antiviral and anti-coronavirus effects. Clinical studies have shown that chloroquine may improve the treatment success rate, shorten the length of stay and improve the prognosis of COVID-19 patients.
We supply this raw materials in drum packing and monthly capacity is10mt with USP grade spec.
News and Events
Contact Info

Simagchem Corporation
Add:Unit 1605,Chuangxiang Center, No.1733 lvling Road, Siming District, Xiamen  
 0086 592 2680277  
 0086 592 2680237

TOP | Copyright 2013 : SIMAGCHEM
Terms & Consitions    |